Transmission status of lymphatic filariasis in hotspots of filarial infection, persistent districts of nepal during post-MDA surveillance
PLOS One · 16.01.2026 · 21 (1) · e0338141
DOI: 10.1371/journal.pone.0338141 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.01.2026. Verfasst von Pramod Kumar Mehta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Zoology, Institute of Science and Technology, Tribhuvan University, Kirtipur, Nepal. Hauptthemen laut MEDLINE: Elephantiasis, Filarial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Commission- Nepal.
Abstract (Originalsprache)
Background
The lymphatic filariasis (LF) elimination program in Nepal was launched in 2003, three years after the implementation of a global program to eliminate lymphatic filariasis globally. Based on antigenic prevalence below the cut-off value, i.e., ≤ 2% shown by the transmission assessment survey (TASI) report of 2017–2018, the program was stopped in Nepal. The report indicated that antigen-positive children were clustered in the community and considered hotspots. In order to find the status of lymphatic filariasis transmission at the community level, the present study was designed in the hotspots to assess antigenemia among the children born after mass drug administration (MDA), along with vector infection/infectivity in identified hotspots of Central Nepal.
Methods
Each of two districts from the hilly and Terai regions of Central Nepal was selected based on comparatively high antigenic prevalence shown by previous TASI reports, and a descriptive cross-sectional study was designed. Two specific methods were employed: a Filarial Test Strip (Alere, Scorborough, ME) was used for antigenemia (n = 791) among children, and gravid traps were used for vector mosquito collection. Parous mosquitoes (n = 3344) were dissected for infection/or infectivity.
Results
The result indicated that antigen-positive cases were unexpectedly increased in hotspots of one each from the hilly region (Dhading) and Terai region (Mahottari), i.e., above the critical level (≥ 2%). Antigen prevalence increased from baseline prevalence, which was significantly associated with the number of MDA rounds but not with MDA coverage. The upper confidence limit of antigenemia and Mf infection was above the critical cut-off value in hotspots of all selected endemic districts. However, none of the vector mosquitoes, such as Culex quinquefasciatus, was found to be infected with any larval stage of filarial nematode.
Conclusions
The result showed an increase in antigenemia and Mf prevalence in high baseline prevalence areas with fewer MDA rounds. Lack of correlation between filarial infection in humans and xenomonitoring could be low sensitivity of xenomonitoring by microscopy. TAS-based assessment of antigenemia in children for stopping MDA can be supplemented with molecular xenomonitoring in hotspots.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Central Department of Zoology, Institute of Science and Technology, Tribhuvan University, Kirtipur, Nepal.
ORCID-Profile: Pramod Kumar Mehta
Förderung
- University Grants Commission- Nepal
Zitieren
APA
Mehta, P. K., & Maharjan, M. (2026). Transmission status of lymphatic filariasis in hotspots of filarial infection, persistent districts of nepal during post-MDA surveillance. PLOS One, 21(1), e0338141. https://doi.org/10.1371/journal.pone.0338141
Vancouver
Mehta PK, Maharjan M. Transmission status of lymphatic filariasis in hotspots of filarial infection, persistent districts of nepal during post-MDA surveillance. PLOS One. 2026;21(1):e0338141. doi:10.1371/journal.pone.0338141
BibTeX
@article{Mehta2026,
author = {Mehta, Pramod Kumar and Maharjan, Mahendra},
title = {Transmission status of lymphatic filariasis in hotspots of filarial infection, persistent districts of nepal during post-MDA surveillance},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {1},
pages = {e0338141},
doi = {10.1371/journal.pone.0338141}
}
EUVIMED